title: Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
abstract: A neutropenic patient with acute myeloid leukaemia experienced a breakthrough infection of Trichosporon asahii during posaconazole treatment. After treatment was changed to a combination therapy with voriconazole and liposomal amphotericin B, the infection resolved. Posaconazole works effectively as an antifungal prophylaxis and salvage therapy in rare invasive fungal infections. This case however illustrates that breakthrough infections with T. asahii may occur during posaconazole treatment.
authors: Department of Hematology/Oncology, University Hospital Grosshadern, Ludwig Maximilian University, Marchioninistrasse 15, 81377, Munich, Germany. christina.rieger@med.uni-muenchen.de
authors: C
authors: C
authors: Rieger
authors: S
authors: S
authors: Geiger
authors: T
authors: T
authors: Herold
authors: C
authors: C
authors: Nickenig
authors: H
authors: H
authors: Ostermann
mesh_terms: D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology*; D004359:Drug Therapy, Combination; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications*; D008297:Male; D009181:Mycoses / Q000188:drug therapy / Q000382:microbiology*; D011743:Pyrimidines / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use*; D014250:Trichosporon / Q000187:drug effects* / Q000302:isolation & purification*; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; C068538:liposomal amphotericin B; C101425:posaconazole; D000666:Amphotericin B; D065819:Voriconazole
references: Antimicrob Agents Chemother. 2002 Apr;46(4):1144-6
references: 11897610
references: N Engl J Med. 2007 Jan 25;356(4):335-47
references: 17251530
references: Support Care Cancer. 1999 Jan;7(1):39-43
references: 9926973
references: Clin Infect Dis. 2006 Oct 15;43(8):1060-8
references: 16983621
references: Scand J Infect Dis. 2004;36(8):564-9
references: 15370667
references: Clin Infect Dis. 2007 Jan 1;44(1):2-12
references: 17143808
references: Eur J Clin Microbiol Infect Dis. 2002 Dec;21(12):892-6
references: 12525928
references: N Engl J Med. 2007 Jan 25;356(4):348-59
references: 17251531
references: Antimicrob Agents Chemother. 2006 Oct;50(10):3269-76
references: 17005804
references: Clin Infect Dis. 1992 Nov;15(5):781-7
references: 1445976